TerrAscend Corp (OTCPK:TSNDF)
$ 0.52 -0.00041 (-0.08%) Market Cap: 161.04 Mil Enterprise Value: 375.06 Mil PE Ratio: 0 PB Ratio: 1.80 GF Score: 44/100

Q2 2026 Terrascend Corp Earnings Call Transcript

Aug 6, 2026 / 09:00 PM GMT
Release Date Price: $0.5217 (+10.76%)

Key Points

Positve
  • TerrAscend Corp (TSNDF) delivered strong Q2 2026 results with revenue of $67.1 million, up 3.3% year-over-year, and gross margin expanding to 54% from 51.1% in the prior year quarter.
  • Adjusted EBITDA from continuing operations reached $17.7 million, a margin of 26.3%, representing 11% year-over-year growth and demonstrating improved operational efficiency.
  • The company generated $7.4 million in operating cash flow and $5.7 million in free cash flow, marking its 16th consecutive quarter of positive operating cash flow and 12th consecutive quarter of positive free cash flow.
  • TerrAscend Corp (TSNDF) successfully completed an oversubscribed convertible financing, raising $21.8 million to retire higher-interest debt, extend maturities to 2031, and reduce blended interest costs.
  • The potential rescheduling of cannabis to Schedule 3 would eliminate the 280E tax burden, materially improving profitability and potentially providing retroactive tax relief, which is not yet reflected in market valuations.
  • Pennsylvania emerged as the fastest-growing core market with revenue up 3.8% sequentially, driven by strong retail execution and leading market share positions in flower, vapes, and extracts.
  • The company maintains a disciplined M&A strategy, focusing on accretive acquisitions in existing markets, with recent deals like Ratio and Union Shell already integrated and St. Mary's expected to be immediately accretive.
Negative
  • Net loss from continuing operations widened to $10.1 million in Q2 2026, compared to a net loss of $6.8 million in the prior quarter, despite revenue growth.
  • G&A expenses increased to $22.9 million from $21.5 million sequentially, driven by one-time costs and merit-based investments in talent, which could pressure future profitability.
  • The company faces ongoing price compression in key markets like New Jersey, where gross margins declined year-over-year despite a 58.5% margin, reflecting intense competitive pressures.
  • Regulatory uncertainty remains a significant overhang, as the timing and outcome of the DEA's rescheduling ruling are unknown, and the company operates independently of reform, limiting near-term upside.
  • The M&A environment is challenging, with sellers still holding unrealistic valuation expectations (7-8 times EBITDA), forcing the company to pass on deals and potentially missing growth opportunities.
  • The proposed share consolidation and potential uplisting to a major US exchange introduce execution risks and require shareholder approval, which may create short-term volatility.
  • While Ohio's hemp enforcement is a positive, the company's growth there is still nascent, and the full impact of regulatory changes on consumer behavior remains uncertain.


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

TSND.TO - Terrascend Corp
Q2 2026 Terrascend Corp Earnings Call
Aug 06, 2026 / 09:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good afternoon, I will be your conference operator today.

At this time?

I would like to welcome everyone to the Terrasand second quarter, 2026 financial results conference call.

I would now like to turn the call over to Walter Pinto, managing director of KCSA Strategic communications for introductions, please go ahead.

Thank you, operator, and good afternoon.

Welcome to the Tan second quarter 2026 financial results conference call.

Joining us for today's call is Jason Wild, executive Chairman, Zia Ganem, President and Chief Executive Officer, and Eric Jackson, Chief Financial Officer.

Our remarks today include forward-looking statements, including statements with respect to
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot